(www.nytimes.com) New drugs are close to market that promise complete cures in more people, with shorter courses and fewer side effects. But they will not be cheap.

Read the rest of this post on the original site »

Recommended Stories

WHO reports five recoveries from rare Ebola strain

Name tweak could boost GLP-1 access for one in eight women suffering PMOS

Congo faces underlying challenges in battle to overcome Ebola: ‘You gotta have safety’